BICLUSTER_ID : UPREG-8
PATHOGENS /1/ : yersinia enterocolitica
TARGETS /71/ : HMGCR, CD44, GCH1, UGCG, CYSLTR2, IFNG, CD86, BRAF, IL2RB, JAK2, PPARG, GSK3B, PDGFRA, F3, CASP1, IL1R1, PGF, CCL20, CCL2, SERPINB2, SULT1E1, PLAU, SLC1A5, PKLR, CCL5, CD55, FGF2, CDK6, ANXA1, NP, IL6, HS3ST3A1, PTGS2, ACSL4, ABP1, TNF, FLT1, MMP13, MMP12, MDM2, AMN, CYP1B1, SLC7A11, CBS, NFKB1, GLRX, ITGB3, HK1, IL1B, PLA2G4A, UAP1, JUN, LDLR, PDE4B, TNFRSF1B, HSP90AA1, SLC7A1, PIM1, TXNRD1, UCK2, CTH, IL12B, OXTR, NR3C1, TAP1, TOP1, BMP2, ADSS, MAPKAPK2, HSPA1A, PLAUR
Gene SetLeading Edge Genes
NETPATH TGFBETA RECEPTOR PATHWAY UPPCNA, HMGCR, HBEGF, ETS1, CLCF1, IFI35, PEG3, EIF2C2, ACTR3, CCND2, PLAG1, KCNA3, INSL6, SERTAD1, JAK2, GTF2B, C5AR1, JUNB, EDN1, MAPK6, TNFRSF12A, NFIL3, CHI3L1, PFKP, TIMP3, IFRD1, F3, JAG1, IL1R1, HIVEP2, MASP2, PGF, CCRN4L, ISGF3G, ELA3A, DLC1, TGFB2, SULT1E1, PLAU, APOA1, CCL5, CXCL11, IER3, FGF2, CDK6, CLU, GDF15, LRRFIP1, MATN3, NP, SPRY2, WISP1, IL6, ATF3, HS3ST3A1, PTGS2, PBEF1, PMP22, CDKN2B, SEMA3C, DDX21, MMP13, GPC1, MAP3K8, CYP1B1, SLC7A11, CDKN2A, CBS, EXT1, FURIN, ETV6, AKT2, BHLHB2, MAPK8, CASP4, EGR2, SGK, FASTK, HMGA1, SPON2, TOPORS, HK1, ERCC1, RASAL2, GADD45B, TIMELESS, SF1, UAP1, JUN, CDKN1A, SOX4, MAPRE2, CRSP2, ARID5A, SLC7A1, PIM1, CTH, UCK2, VIM, DSCR1, PTPRC, IVL, IL9, ETS2, MAPKAPK2, DAXX, PLAUR
NETPATH TGFBETA RECEPTOR PATHWAY DOWNCLCN7, SOD3, UGCG, PLAG1, CCND2, NFKBIZ, IFIT1, CXCL1, CSF1, EDN1, CDC6, PPARG, MAPK6, PDGFRA, BYSL, NFIL3, LCP2, TIMP3, AKAP2, F3, IFRD1, TNFAIP3, CASP1, ADM, IL1R1, PPAP2B, PCDH7, EPAS1, CDK5R1, CCL2, PDLIM3, TGFB2, PLAU, SULT1E1, CCL7, PKLR, SOCS1, CDK6, ADAMTS1, GDF15, CITED2, SLC5A5, ATF3, ACSL4, ID2, PCF11, MMP13, MAP3K8, SLPI, CYP1B1, EDG2, AREG, AKT2, CLDN1, CASP4, EGR2, FASTK, PPA1, GBP2, IL1B, NAT6, AHR, JUN, EVI2A, SF1, CDKN1A, IL1RN, IFIT3, SASH1, ANGPT2, SDC4, PLEKHQ1, TXNRD1, MSR1, IFIT2, LIF, PHLDA1, OXTR, PLK2, GYPC, TAP1, BMP2, TBX3, MAPKAPK2, DAXX
NETPATH IL 2 PATHWAY UPPCNA, SFPQ, EIF1, NOLC1, CISH, OLIG2, ETS1, NMI, RGS16, PMAIP1, ITGAM, CCND2, IFNG, CFLAR, IFIT1, IL2RB, SP100, LPIN2, CSF1, PITRM1, TNFSF10, IL10, NFIL3, ATF4, LCP2, CASP1, IL1R1, UPP1, MASP2, GBP1, ISGF3G, PLAU, SLC1A5, SOCS1, IER3, TRIM21, PRKX, IL6, ID2, PBEF1, MX1, TNF, DDX21, FURIN, IFI44, BHLHB2, SGK, NFKB1, B4GALT5, IL18R1, CASP9, GADD45G, SRC, PTP4A1, IFITM3, RGS1, CCL3, IL1B, IRF1, BLM, AHR, PDE4B, JUN, LDLR, FRMD4B, TNFRSF1B, MLLT3, SOCS3, TRAFD1, TITF1, PIM1, CSF2, TXNRD1, CCL4, SLC30A1, UCK2, KLF6, LIF, VIM, TOP1, CCR1, PTPRC, IL9, ETS2, SNTB1, MAPKAPK2, DAXX, STIP1, PLAUR
NETPATH IL 1 PATHWAY UPCCL20, MMP12, MMP14, JUN, CCL2, HBEGF, SERPINB2, PRG1, RARS, CCL7, SOD3, MT2A, IFNG, CXCL2, TXNRD1, PTX3, CCL4, NFKB1, LIF, CXCL1, PLK2, NP, IL1A, CXCL5, IL6, PTGS2, IL1B, PBEF1, ZFP36
NETPATH IL 4 PATHWAY UPELL2, ARID5B, CH25H, CYP1B1, RASA2, LRRTM2, EXT1, CD86, AIM1, IFNG, RIPK2, EGR2, NFKB1, MCM3, IBRDC3, MAF, IL10, RBMS1, NFIL3, TIMP3, F3, JAG1, UPP1, AHR, SLC38A1, PCDH7, ETV3, JUN, CCL2, MCM2, SOCS3, IL1RN, SOCS1, MCM4, PTX3, ANXA1, MXD1, REL, KLF4, CITED2, BMP2, IL6, DKK2, RSAD2, TCF7, CTSL, SLC11A2
NCI REG GR PATHWAYCDK5R1, CDKN1A, JUN, MDM2, HSP90AA1, EGR1, IFNG, MAPK8, SGK, NFKB1, SMARCC1, NR1I3, NR3C1, GSK3B, AFP, IL6, IRF1
NCI IL23PATHWAYNFKB1, IL12B, CXCL1, JAK2, CCL2, IL18R1, SOCS3, IL6, IL1B, IL23A, IFNG, CXCL9, TNF
NETPATH IL 5 PATHWAY UPNFKBIB, PLSCR1, HMGCR, SFPQ, CCL2, CD44, HBEGF, EGR1, PIM1, CD55, CD24, IER3, EGR2, CASP4, SGK, NFKB1, REL, MAPK6, IL1A, CCR1, NFIL3, LCP2, ATF4, ACP5, CCL3, IL1B, PMP22, ABP1, UPP1
GERY CEBP TARGETSGADD45B, HMGCR, EREG, SLFN2, HBEGF, SLFN4, SERPINB2, IFI203 /// IFI204 //, GCH1, PIM1, MAFK, DNAJB10, PTX3, CLU, CXCL1, GLRX, JUNB, KLF4, MYD116, IFI204 /// LOC672547, GADD45G, CXCL5, ATF3, IFRD1, ID2, TGTP, PLAUR, DUSP1, HSPA1A
NCI IL12 2PATHWAYNFKB1, MAP2K3, IL2RB, IL12B, GADD45B, JAK2, NFKB2, IL18R1, GADD45G, CCL3, IL1B, SOCS1, RIPK2, IFNG, IL1R1, CCL4
NETPATH IL 4 PATHWAY DOWNCCL20, GADD45B, CDKN1A, IL7R, CCL2, SPP1, AMN, ITPKB, CYSLTR2, CXCL2, VIM, TNFSF10, GBP2, CHI3L1, IL6, TLR3, GEM, PTGS2, TCF7, IRF1, MX1, TNF
NETPATH KIT RECEPTOR PATHWAY UPPLA2G4A, GDF15, JUNB, CCL2, CXCR3, IL9, ATF4, IL6, EGR1, SOCS1, CCL5, PIM1, TXNRD1, TNF, IER3
NETPATH TNF ALPHA PATHWAY DOWNCCL20, JUN, VLDLR, EGR1, EXT1, SDC4, CXCL2, BHLHB2, REL, KLF6, CXCL1, PLK2, JUNB, FOSB, NR3C1, MAPK6, GSK3B, TIPARP, MAFF, DUSP2, IL6, GEM, PTGS2, TNFAIP3, ZFP36, IRF1, HSPA1A
NCI IL27PATHWAYIL12B, IL6, IL1B, JAK2, STAT2, IFNG, TNF
NETPATH EGFR1 PATHWAY UPEMP1, CDKN1A, EREG, HBEGF, PPP1R10, SERPINB2, PLAU, EGR1, AREG, SDC4, IER3, PHLDA1, LIF, PLK2, NP, SPRY2, EHD1, ADSS, CXCL5, PTGS2, TNFAIP3, DUSP1, PLAUR
NETPATH IL 7 PATHWAY UPFASTK, CXCL1, JUN, CD44, CXCL5, CCL3, CCL5, CD86, CXCL2, BRAF, CCL4
NCI ATF2 PATHWAYDUSP10, JUN, PDGFRA, TGFB2, SOCS3, PLAU, IL6, ATF3, IL23A, CUL3, IFNG, DUSP8, DUSP1
NETPATH IL 3 PATHWAY UPCSF1, CCL2, CISH, CCR1, NFIL3, SOCS3, CCL7, IL1B, CCL3, SOCS1, PIM1, CD86, TNF, CCL4
NCI AR TF PATHWAYSIRT1, SMARCC1, REL, JUN, NR3C1, MDM2, GSK3B, HSP90AA1, SRC, EGR1, GATA2, MAPK8
NETPATH IL 1 PATHWAYNFKB1, NFKBIB, PELI1, IL1A, IL1RN, IL1B, CASP1, IL1R1, TRAF6, TOLLIP
NCI IL1PATHWAYNFKB1, JUN, IL1A, SQSTM1, IL1RN, IL1B, IL1R1, TRAF6
NETPATH IL 6 PATHWAY UPGADD45B, JUN, CD44, CISH, MAP3K8, SOCS3, SOCS1, PIM1, BHLHB2, CLU, CXCL1, JUNB, CITED2, MAFF, ZFP36, ID2, IRF1, TNF, MX1
NCI IL12 STAT4PATHWAYJUN, IRF1, IL18R1, IFNG, CD86, CD247, CD3D, MAPK8
SA MMP CYTOKINE CONNECTIONCSF1, IL1B, CD44, TGFB2, TNF
NCI IL4 2PATHWAYPARP14, RETNLB, IRS2, JAK2, JAK3, IL13RA2, IL10, CBL, ETS1, ITGB3, HMGA1, SOCS3, SOCS1, EGR2
NETPATH IL 9 PATHWAY UPSOCS3, CCL7, CCL3, CCL2, JUNB, CITED2, PIM1
NCI NFKAPPABCANONICALPATHWAYTNFAIP3, RIPK2, TRAF6, FBXW11, TNF
NCI ERBB NETWORK PATHWAYNRG3, AREG, EREG, HBEGF, HSP90AA1
NCI HIF2PATHWAYTWIST1, MMP14, EPAS1, FXN, CITED2, BHLHB2, SLC11A2, FLT1
BIOCARTA IL10 PATHWAY
NCI S1P S1P1 PATHWAY
MAHAJAN RESPONSE TO IL1A UP
WEINMANN ADAPTATION TO HYPOXIA DN
MASSARWEH TAMOXIFEN RESISTANCE UP
LI CISPLATIN RESISTANCE UP
LINDSTEDT DENDRITIC CELL MATURATION B
BIOCARTA IL1R PATHWAY
HUANG FOXA2 TARGETS DN
RADAEVA RESPONSE TO IFNA1 UP
SESTO RESPONSE TO UV C0
BOWIE RESPONSE TO EXTRACELLULAR MATRIX
MISHRA CARCINOMA ASSOCIATED FIBROBLAST UP
WANG SMARCE1 TARGETS UP
JEON SMAD6 TARGETS UP
NCI DISSOLUTION OF FIBRIN CLOT
MASRI RESISTANCE TO TAMOXIFEN AND AROMATASE INHIBITORS UP
BOYAULT LIVER CANCER SUBCLASS G56 DN
AGARWAL AKT PATHWAY TARGETS
DORN ADENOVIRUS INFECTION 48HR DN
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
NCI HIF1 TFPATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR UP
AMIT EGF RESPONSE 240 MCF10A
AMIT SERUM RESPONSE 60 MCF10A
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS MAGENTA UP
HAN SATB1 TARGETS DN
MCBRYAN PUBERTAL BREAST 3 4WK UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION MONOCYTE UP
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
SEITZ NEOPLASTIC TRANSFORMATION BY 8P DELETION UP
SENGUPTA NASOPHARYNGEAL CARCINOMA UP
FRASOR TAMOXIFEN RESPONSE UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLUE UP
KOKKINAKIS METHIONINE DEPRIVATION 96HR DN
AMIT EGF RESPONSE 120 HELA
VART KSHV INFECTION ANGIOGENIC MARKERS DN
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP
MCLACHLAN DENTAL CARIES UP
GAJATE RESPONSE TO TRABECTEDIN UP
HELLER SILENCED BY METHYLATION UP
NCI ACTIVATION OF NOXA AND TRANSLOCATION TO MITOCHONDRIA
GOZGIT ESR1 TARGETS DN
NCI P38ALPHABETAPATHWAY
BIOCARTA MONOCYTE PATHWAY
SMID BREAST CANCER LUMINAL B DN
BERNARD PPAPDC1B TARGETS DN
SASSON RESPONSE TO GONADOTROPHINS DN
CORUM REL-MAP3K8-RELA-TNIP2-PAPOLA COMPLEX
DORN ADENOVIRUS INFECTION 24HR DN
PUIFFE INVASION INHIBITED BY ASCITES DN
MARSON FOXP3 TARGETS STIMULATED UP
FALVELLA SMOKERS WITH LUNG CANCER
VERHAAK AML WITH NPM1 MUTATED UP
AMIT EGF RESPONSE 40 MCF10A
REACTOME G ALPHA I SIGNALLING EVENTS
SPIRA SMOKERS LUNG CANCER UP
CORUM IKBEPSILON-RELA-CREL COMPLEX
ST TUMOR NECROSIS FACTOR PATHWAY
CAIRO LIVER DEVELOPMENT UP
CHASSOT SKIN WOUND
TIAN TNF SIGNALING VIA NFKB
ST STAT3 PATHWAY
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
MURAKAMI UV RESPONSE 1HR DN
CORUM NFKB1-NFKB2-REL-RELA-RELB COMPLEX
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
MISSIAGLIA REGULATED BY METHYLATION UP
CREIGHTON ENDOCRINE THERAPY RESISTANCE 5
BROWNE HCMV INFECTION 12HR UP
SESTO RESPONSE TO UV C1
BROWNE HCMV INFECTION 24HR DN
MARIADASON RESPONSE TO CURCUMIN SULINDAC 5
SIMBULAN UV RESPONSE NORMAL UP
KIM LRRC3B TARGETS
CHIANG LIVER CANCER SUBCLASS UNANNOTATED UP
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
LIN NPAS4 TARGETS DN
NCI LYSOPHOSPHOLIPID PATHWAY
KEGG PRION DISEASES
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS GREY DN
FUNG IL2 SIGNALING 2
SCHAVOLT TARGETS OF TP53 AND TP63
NIKOLSKY BREAST CANCER 1Q32 AMPLICON
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLACK UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
DIRMEIER LMP1 RESPONSE LATE UP
SEIKE LUNG CANCER POOR SURVIVAL
BIOCARTA CYTOKINE PATHWAY
MARZEC IL2 SIGNALING UP
CHIBA RESPONSE TO TSA DN
ENK UV RESPONSE EPIDERMIS DN
BIOCARTA PPARA PATHWAY
BOYLAN MULTIPLE MYELOMA C D DN
LE EGR2 TARGETS DN
CROMER TUMORIGENESIS UP
FRIDMAN SENESCENCE UP
CORUM ITGAV-ITGB3-PPAP2B COMPLEX
WU HBX TARGETS 2 DN
IVANOVA HEMATOPOIESIS STEM CELL
MAHADEVAN RESPONSE TO MP470 UP
CORRE MULTIPLE MYELOMA UP
FERRARI RESPONSE TO FENRETINIDE UP
NCI AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE
BIOCARTA TID PATHWAY
LE SKI TARGETS UP
SANA RESPONSE TO IFNG UP
BOYLAN MULTIPLE MYELOMA PCA1 UP
WU HBX TARGETS 1 UP
KORKOLA EMBRYONIC CARCINOMA VS SEMINOMA DN
SENGUPTA NASOPHARYNGEAL CARCINOMA WITH LMP1 UP
MURAKAMI UV RESPONSE 6HR UP
DACOSTA ERCC3 ALLELE XPCS VS TTD DN
MOSERLE IFNA RESPONSE
OUELLET CULTURED OVARIAN CANCER INVASIVE VS LMP DN
WANG METHYLATED IN BREAST CANCER
BECKER TAMOXIFEN RESISTANCE DN
REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL
ODONNELL TARGETS OF MYC AND TFRC UP
ONDER CDH1 TARGETS 1 DN
BIOCARTA GRANULOCYTES PATHWAY
LINDSTEDT DENDRITIC CELL MATURATION C
SHAFFER IRF4 TARGETS IN ACTIVATED DENDRITIC CELL
DORSAM HOXA9 TARGETS DN
ELVIDGE HYPOXIA BY DMOG UP
MIZUKAMI HYPOXIA UP
TURASHVILI BREAST LOBULAR CARCINOMA VS DUCTAL NORMAL UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
KIM WT1 TARGETS 8HR UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
ELVIDGE HIF1A TARGETS DN
LI CISPLATIN RESISTANCE DN
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D UP
HAHTOLA SEZARY SYNDROM DN
REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS
PEREZ TP53 AND TP63 TARGETS
REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS
CORUM MT1-MMP-CLAUDIN-1 COMPLEX
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
MUELLER COMMON TARGETS OF AML FUSIONS DN
GAUSSMANN MLL AF4 FUSION TARGETS E DN
CHEN LVAD SUPPORT OF FAILING HEART UP
HELLER HDAC TARGETS SILENCED BY METHYLATION DN
MCBRYAN PUBERTAL BREAST 4 5WK UP
KYNG DNA DAMAGE BY 4NQO OR GAMMA RADIATION
KORKOLA EMBRYONIC CARCINOMA VS SEMINOMA UP
VECCHI GASTRIC CANCER EARLY DN
TSENG IRS1 TARGETS DN
XU HGF TARGETS REPRESSED BY AKT1 UP
CORUM IKBBETA-RELA-CREL COMPLEX
NCI SYNDECAN 1 PATHWAY
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
BIOCARTA NKT PATHWAY
MORI EMU MYC LYMPHOMA BY ONSET TIME DN
ZHAN MULTIPLE MYELOMA CD2 UP
NCI IL6 7PATHWAY
BROWNE INTERFERON RESPONSIVE GENES
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D DN
NIKOLSKY BREAST CANCER 17Q11 Q21 AMPLICON
LIEN BREAST CARCINOMA METAPLASTIC
CORUM CELL CYCLE KINASE COMPLEX CDC2
ROETH TERT TARGETS UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
BIOCARTA LAIR PATHWAY
DAZARD UV RESPONSE CLUSTER G3
OSADA ASCL1 TARGETS DN
NUYTTEN EZH2 TARGETS UP
BIOCARTA LYM PATHWAY
DUTTA APOPTOSIS VIA NFKB
NCI REMOVAL OF AMINOTERMINAL PROPEPTIDES FROM GAMMA CARBOXYLATED PROTEINS
NCI NECTIN PATHWAY
DER IFN GAMMA RESPONSE UP
DAZARD UV RESPONSE CLUSTER G4
MCMURRAY TP53 HRAS COOPERATION RESPONSE UP
ZHOU INFLAMMATORY RESPONSE LIVE UP
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
BIOCARTA ERYTH PATHWAY
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
HOQUE METHYLATED IN CANCER
NEWMAN ERCC6 TARGETS UP
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX CHUK KPNA3 NFKB2 NFKBIB REL IKBKG NFKB1 NFKBIE RELB NFKBIA RELA TNIP2
NETPATH HEDGEHOG PATHWAY UP
FOSTER INFLAMMATORY RESPONSE LPS DN
GAURNIER PSMD4 TARGETS
FARMER BREAST CANCER CLUSTER 1
GRANDVAUX IFN RESPONSE NOT VIA IRF3
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
MARKEY RB1 CHRONIC LOF DN
CORUM TOP1-PSF-P54 COMPLEX
BOQUEST STEM CELL CULTURED VS FRESH DN
GESERICK TERT TARGETS DN
AMIT SERUM RESPONSE 120 MCF10A
LEE LIVER CANCER MYC E2F1 UP
NCI IL2 1PATHWAY
WAMUNYOKOLI OVARIAN CANCER GRADES 1 2 DN
GEISS RESPONSE TO DSRNA UP
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX RPL6 RPL30 RPS13 CHUK DDX3X NFKB2 NFKBIB REL IKBKG NFKB1 MAP3K8 RELB GLG1 NFKBIA RELA TNIP2 GTF2I
GENTILE UV HIGH DOSE DN
BOYLAN MULTIPLE MYELOMA C CLUSTER DN
ZHOU INFLAMMATORY RESPONSE FIMA UP
REACTOME GPCR LIGAND BINDING
GRUETZMANN PANCREATIC CANCER UP
ST PAC1 RECEPTOR PATHWAY
OKUMURA INFLAMMATORY RESPONSE LPS
ABE VEGFA TARGETS 2HR
VALK AML CLUSTER 2
KRIGE AMINO ACID DEPRIVATION
KOMMAGANI TP63 GAMMA TARGETS
AMIT EGF RESPONSE 60 MCF10A
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
CHEN HOXA5 TARGETS 6HR UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
LEONARD HYPOXIA
BONCI TARGETS OF MIR15A AND MIR16 1
CHEN LVAD SUPPORT OF FAILING HEART DN
DORN ADENOVIRUS INFECTION 32HR DN
WU CELL MIGRATION
WALLACE PROSTATE CANCER RACE UP
CHANDRAN METASTASIS DN
NETPATH IL 7 PATHWAY DOWN
BIOCARTA CCR5 PATHWAY
KEGG MAPK SIGNALING PATHWAY
ONDER CDH1 SIGNALING VIA CTNNB1
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
ZHONG RESPONSE TO AZACITIDINE AND TSA UP
BIOCARTA IL12 PATHWAY
UROSEVIC RESPONSE TO IMIQUIMOD
BROWNE HCMV INFECTION 30MIN UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA UP
KOKKINAKIS METHIONINE DEPRIVATION 48HR UP
WU HBX TARGETS 2 UP
WILLERT WNT SIGNALING
SWEET LUNG CANCER KRAS DN
TSAI DNAJB4 TARGETS DN
BIOCARTA DC PATHWAY
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 6
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
LI PROSTATE CANCER EPIGENETIC
GOLDRATH ANTIGEN RESPONSE
BILD HRAS ONCOGENIC SIGNATURE
DAUER STAT3 TARGETS UP
LIANG SILENCED BY METHYLATION 2
RIGGI EWING SARCOMA PROGENITOR DN
DER IFN ALPHA RESPONSE UP
MENSE HYPOXIA UP
NCI TRAFFICKING OF AMPA RECEPTORS
PETRETTO CARDIAC HYPERTROPHY
REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION
BERENJENO TRANSFORMED BY RHOA FOREVER DN
AMIT EGF RESPONSE 60 HELA
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
DAZARD UV RESPONSE CLUSTER G2
AMUNDSON DNA DAMAGE RESPONSE TP53
MARKS HDAC TARGETS DN
MCLACHLAN DENTAL CARIES DN
KEGG ALLOGRAFT REJECTION
NCI P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
BIOCARTA INFLAM PATHWAY
SANA TNF SIGNALING UP
SENESE HDAC1 AND HDAC2 TARGETS UP
AMIT EGF RESPONSE 240 HELA
SHI SPARC TARGETS DN
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
GRAHAM CML QUIESCENT VS NORMAL QUIESCENT UP
CASTELLANO NRAS TARGETS UP
CORUM TLE-HISTONE H3 COMPLEXHIST1H3D, TLE2, TLE4, H3F3B, TLE1
KEGG HEMATOPOIETIC CELL LINEAGE
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 2
VICENT METASTASIS DN
SHAFFER IRF4 TARGETS IN ACTIVATED B LYMPHOCYTE
VECCHI GASTRIC CANCER ADVANCED VS EARLY UP
KUROKAWA LIVER CANCER CHEMOTHERAPY DN
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
BIOCARTA KERATINOCYTE PATHWAY
CORUM UBIQUITIN LIGASE COMPLEX TRAF6 TAB2 MALT1 UEV1A BCL10
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS UP
CHIBA RESPONSE TO TSA UP
HELLER HDAC TARGETS DN
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
CROONQUIST NRAS VS STROMAL STIMULATION DN
GOUYER TATI TARGETS UP
ZHAN MULTIPLE MYELOMA HP UP
NCI GLUCOSE ATP GLUCOSE 6 PHOSPHATE ADP
LU IL4 SIGNALING
WATTEL AUTONOMOUS THYROID ADENOMA DN
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
BIOCARTA STEM PATHWAY
SNIJDERS AMPLIFIED IN HEAD AND NECK TUMORS
BIOCARTA NFKB PATHWAY
VANHARANTA UTERINE FIBROID DN
LINDGREN BLADDER CANCER CLUSTER 2B
CHUANG OXIDATIVE STRESS RESPONSE UP
KEGG GRAFT VERSUS HOST DISEASE
VARELA ZMPSTE24 TARGETS UP
ONDER CDH1 TARGETS 2 UP
REACTOME PEPTIDE LIGAND BINDING RECEPTORS
NGUYEN NOTCH1 TARGETS UP
BRUECKNER TARGETS OF MIRLET7A3 DN
KRASNOSELSKAYA ILF3 TARGETS UP
RASHI RESPONSE TO IONIZING RADIATION 2
CORUM CDC2-PCNA-CCNB1-GADD45B COMPLEX
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
ODONNELL TFRC TARGETS UP
GRAHAM CML QUIESCENT VS NORMAL QUIESCENT DN
IYENGAR RESPONSE TO ADIPOCYTE FACTORS
AMIT EGF RESPONSE 40 HELA
KIM WT1 TARGETS 12HR DN
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS YELLOW DN
BILD CTNNB1 ONCOGENIC SIGNATURE
MITSIADES RESPONSE TO APLIDIN UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
HINATA NFKB TARGETS KERATINOCYTE UP
MARKEY RB1 ACUTE LOF UP
XU AKT1 TARGETS 6HR
KEGG TYPE II DIABETES MELLITUS
HUANG FOXA2 TARGETS UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D DN
POOLA INVASIVE BREAST CANCER UP
SABATES COLORECTAL ADENOMA UP
WOTTON RUNX TARGETS UP
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY DN
LIU VAV3 PROSTATE CARCINOGENESIS UP
BROWNE HCMV INFECTION 6HR UP
DAUER STAT3 TARGETS DN
BIOCARTA RANKL PATHWAY
DANG REGULATED BY MYC DN
NCI CHEMOKINE RECEPTORS BIND CHEMOKINES
STOSSI RESPONSE TO ESTRADIOL
BOYLAN MULTIPLE MYELOMA D CLUSTER UP
CORUM PLEXINA1-NRP2 COMPLEX
WHITESIDE CISPLATIN RESISTANCE UP
SHAFFER IRF4 TARGETS IN PLASMA CELL VS MATURE B LYMPHOCYTE
PODAR RESPONSE TO ADAPHOSTIN UP
JAATINEN HEMATOPOIETIC STEM CELL DN
KAPOSI LIVER CANCER POOR SURVIVAL UP
LEE LIVER CANCER E2F1 UP
PARK TRETINOIN RESPONSE AND RARA PLZF FUSION
BOWIE RESPONSE TO TAMOXIFEN
GAUSSMANN MLL AF4 FUSION TARGETS D DN
HEIDENBLAD AMPLIFIED IN BONE CANCER
ZHOU INFLAMMATORY RESPONSE LPS UP
ICHIBA GRAFT VERSUS HOST DISEASE 35D UP
SUNG METASTASIS STROMA UP
VANTVEER BREAST CANCER ESR1 DN
STEARMAN LUNG CANCER EARLY VS LATE DN
BROCKE APOPTOSIS REVERSED BY IL6
LY AGING MIDDLE DN
RUGO STRESS RESPONSE SUBSET F
BARRIER COLON CANCER RECURRENCE DN
NCI P53DOWNSTREAMPATHWAY
BIOCARTA ATM PATHWAY
BOYLAN MULTIPLE MYELOMA PCA3 UP
GENTILE UV LOW DOSE UP
BIOCARTA P53HYPOXIA PATHWAY
HUANG DASATINIB RESISTANCE UP
PEREZ TP63 TARGETS
HINATA NFKB TARGETS FIBROBLAST UP
ZHANG INTERFERON RESPONSE
JI METASTASIS REPRESSED BY STK11
CHANG IMMORTALIZED BY HPV31 DN
CROONQUIST STROMAL STIMULATION UP
CHIARADONNA NEOPLASTIC TRANSFORMATION CDC25 UP
KANG GIST WITH PDGFRA UP
CORUM BRCA1 B COMPLEX
KINSEY TARGETS OF EWSR1 FLII FUSION DN
LI WILMS TUMOR VS FETAL KIDNEY 1 UP
KHETCHOUMIAN TRIM24 TARGETS UP
HORIUCHI WTAP TARGETS UP
WOO LIVER CANCER RECURRENCE UP
DORN ADENOVIRUS INFECTION 12HR UP
DAVICIONI TARGETS OF PAX FOXO1 FUSIONS UP
HENDRICKS SMARCA4 TARGETS UP
RIGGI EWING SARCOMA PROGENITOR UP
CLASPER LYMPHATIC VESSELS DURING METASTASIS DN
BUDHU LIVER CANCER METASTASIS DN
KEGG JAK STAT SIGNALING PATHWAY
TURASHVILI BREAST DUCTAL CARCINOMA VS DUCTAL NORMAL DN
TSAI DNAJB4 TARGETS UP
DER IFN BETA RESPONSE UP
SHEDDEN LUNG CANCER GOOD SURVIVAL A4
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D DN
SCHLESINGER METHYLATED DE NOVO IN CANCER
BASSO CD40 SIGNALING UP
MUELLER METHYLATED IN GLIOBLASTOMA
NCI ERBB4 PATHWAY
WILLIAMS ESR1 TARGETS UP
TIAN TNF SIGNALING NOT VIA NFKB
CHANG POU5F1 TARGETS UP
NAGASHIMA NRG1 SIGNALING UP
ZERBINI RESPONSE TO SULINDAC UP
WANG ESOPHAGUS CANCER VS NORMAL UP
FRASOR RESPONSE TO ESTRADIOL DN
REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS
TSENG ADIPOGENIC POTENTIAL DN
NETPATH B CELL RECEPTOR PATHWAY UP
SCHURINGA STAT5A TARGETS UP
SASSON RESPONSE TO FORSKOLIN DN
SMID BREAST CANCER NORMAL LIKE UP
BIOCARTA P53 PATHWAY
CADWELL ATG16L1 TARGETS UP
KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY
MATTIOLI MULTIPLE MYELOMA WITH 14Q32 TRANSLOCATIONS
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
CREIGHTON ENDOCRINE THERAPY RESISTANCE 4
SIG CD40PATHWAYMAP
KEGG LEISHMANIA INFECTION
YAO HOXA10 TARGETS VIA PROGESTERONE DN
ELVIDGE HIF1A AND HIF2A TARGETS DN
MASSARWEH RESPONSE TO ESTRADIOL
FUNG IL2 SIGNALING 1
CHEN HOXA5 TARGETS 9HR UP
WANG RECURRENT LIVER CANCER DN
RORIE TARGETS OF EWSR1 FLI1 FUSION UP
SEKI INFLAMMATORY RESPONSE LPS UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
ENGELMANN CANCER PROGENITORS UP
LEE RECENT THYMIC EMIGRANT
BUYTAERT PHOTODYNAMIC THERAPY STRESS UP
FOSTER INFLAMMATORY RESPONSE LPS UP
BIOCARTA ASBCELL PATHWAY
SENESE HDAC1 TARGETS UP
LIU TARGETS OF VMYB VS CMYB DN
KIM WT1 TARGETS UP
KEGG CYTOSOLIC DNA SENSING PATHWAY
WANG HCP PROSTATE CANCER
BROWNE HCMV INFECTION 1HR UP
HESS TARGETS OF HOXA9 AND MEIS1 DN
AMIT EGF RESPONSE 120 MCF10A
IIZUKA RECURRENT LIVER CANCER
NETPATH WNT PATHWAY UP
SMID BREAST CANCER RELAPSE IN BONE DN
BERENJENO ROCK SIGNALING NOT VIA RHOA DN
RUTELLA RESPONSE TO HGF UP
HOSHIDA LIVER CANCER LATE RECURRENCE UP
PRAMOONJAGO SOX4 TARGETS UP
REACTOME CRMPS IN SEMA3A SIGNALING
LU TUMOR ENDOTHELIAL MARKERS UP
REACTOME INORGANIC CATION ANION SLC TRANSPORTERS
BIOCARTA PML PATHWAY
LENAOUR DENDRITIC CELL MATURATION UP
MARCHINI TRABECTEDIN RESISTANCE DN
TENEDINI MEGAKARYOCYTE MARKERS
SAKAI CHRONIC HEPATITIS VS LIVER CANCER DN
LINDSTEDT DENDRITIC CELL MATURATION A
REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS
XU RESPONSE TO TRETINOIN UP
BASAKI YBX1 TARGETS DN
HOFMANN CELL LYMPHOMA DN
ELVIDGE HYPOXIA UP
WATANABE ULCERATIVE COLITIS WITH CANCER DN
STEIN ESTROGEN RESPONSE NOT VIA ESRRA
FARMER BREAST CANCER BASAL VS LULMINAL
RIZ ERYTHROID DIFFERENTIATION 12HR
NUYTTEN NIPP1 TARGETS UP
ST TYPE I INTERFERON PATHWAY
GENTILE UV RESPONSE CLUSTER D1
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
NCI GAMMA CARBOXYLATION OF PROTEIN PRECURSORS
MURATA VIRULENCE OF H PILORI
VART KSHV INFECTION ANGIOGENIC MARKERS UP
DAVICIONI PAX FOXO1 SIGNATURE IN ARMS DN
BIOCARTA IL22BP PATHWAY
ROZANOV MMP14 TARGETS DN
TSAI RESPONSE TO IONIZING RADIATION
DELYS THYROID CANCER UP
DIRMEIER LMP1 RESPONSE EARLY
AMIT SERUM RESPONSE 240 MCF10A
SEMENZA HIF1 TARGETS
MISHRA CARCINOMA ASSOCIATED FIBROBLAST DN
BENNETT SYSTEMIC LUPUS ERYTHEMATOSUS
BIOCARTA ETS PATHWAY
NCI NFAT TFPATHWAY
ONDER CDH1 TARGETS 3 DN
CORUM PCNA-P21 COMPLEX
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
HELLEBREKERS SILENCED DURING TUMOR ANGIOGENESIS
LIAN LIPA TARGETS 6M
DAZARD RESPONSE TO UV NHEK UP
WINTER HYPOXIA METAGENE
BROWNE HCMV INFECTION 8HR UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS TURQUOISE UP
TAVOR CEBPA TARGETS UP
RAY ALZHEIMERS DISEASE
OSAWA TNF TARGETS
SASAKI TARGETS OF TP73 AND TP63
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA UP
NETPATH TNF ALPHA PATHWAY UP
NCI AMB2 NEUTROPHILS PATHWAY
NOJIMA SFRP2 TARGETS DN
NGUYEN NOTCH1 TARGETS DN
BROWNE HCMV INFECTION 2HR UP
WANG RESPONSE TO PACLITAXEL VIA MAPK8 UP
KIM WT1 TARGETS 12HR UP
ZIRN TRETINOIN RESPONSE UP
SESTO RESPONSE TO UV C3
HASLINGER B CLL WITH MUTATED VH GENES
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
SENESE HDAC2 TARGETS UP
GRANDVAUX IRF3 TARGETS UP
KIM MYCN AMPLIFICATION TARGETS DN
ROZANOV MMP14 TARGETS UP
ZHU CMV ALL UP
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
KEGG TYPE I DIABETES MELLITUS
AMIT DELAYED EARLY GENES
NOJIMA SFRP2 TARGETS UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
NETPATH EGFR1 PATHWAY DOWN
RICKMAN TUMOR DIFFERENTIATED WELL VS MODERATELY DN
SATO SILENCED EPIGENETICALLY IN PANCREATIC CANCER
RUIZ TNC TARGETS UP
RODRIGUES THYROID CARCINOMA DN
AUJLA IL22 AND IL17A SIGNALING
LEE LIVER CANCER MYC TGFA UP
DAZARD RESPONSE TO UV SCC UP
HALMOS CEBPA TARGETS UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D UP
SAGIV CD24 TARGETS DN
AUNG GASTRIC CANCER
NETPATH IL 7 PATHWAY
DAVICIONI TARGETS OF PAX FOXO1 FUSIONS DN
WIELAND UP BY HBV INFECTION
REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE
MAHADEVAN RESPONSE TO MP470 DN
RIGGINS TAMOXIFEN RESISTANCE DN
LEE INTRATHYMIC T PROGENITOR
TSAI RESPONSE TO RADIATION THERAPY
NCI CXCR3PATHWAY
HARRIS HYPOXIA
CORUM SNRNP-FREE U1A SF-A COMPLEXDDX5, SFPQ
NCI BH3 ONLY PROTEINS ASSOCIATE WITH AND INACTIVATE ANTI APOPTOTIC BCL 2 MEMBERS
RUIZ TNC TARGETS DN
KAN RESPONSE TO ARSENIC TRIOXIDE
SOUCEK MYC TARGETS
BIOCARTA IL5 PATHWAY
SCIAN INVERSED TARGETS OF TP53 AND TP73 DN
BILBAN B CLL LPL DN
IZADPANAH STEM CELL ADIPOSE VS BONE UP
GENTILE UV LOW DOSE DN
ZHAN MULTIPLE MYELOMA LB DN
KEGG AUTOIMMUNE THYROID DISEASE
SHAFFER IRF4 MULTIPLE MYELOMA PROGRAM
CHIN BREAST CANCER COPY NUMBER UP
WILCOX PRESPONSE TO ROGESTERONE DN
WANG ESOPHAGUS CANCER PROGRESSION UP
EINAV INTERFERON SIGNATURE IN CANCER
LEE SP4 THYMOCYTE
CHANG POU5F1 TARGETS DN
AMIT SERUM RESPONSE 40 MCF10A
GUENTHER GROWTH SPHERICAL VS ADHERENT DN
HELLER HDAC TARGETS SILENCED BY METHYLATION UP
MASSARWEH TAMOXIFEN RESISTANCE DN
BROWNE HCMV INFECTION 4HR UP
WONG ENDOMETRIAL CANCER LATE
BIOCARTA HSP27 PATHWAY
ZHU CMV 8 HR UP
HELLER SILENCED BY METHYLATION DN
BIERIE INFLAMMATORY RESPONSE TGFB1
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D UP
SCHUETZ BREAST CANCER DUCTAL INVASIVE UP
XU HGF TARGETS INDUCED BY AKT1 6HR
ONDER CDH1 TARGETS 2 DN
GRADE COLON VS RECTAL CANCER UP
UDAYAKUMAR MED1 TARGETS DN
SENESE HDAC3 TARGETS UP
LIAN LIPA TARGETS 3M
KEGG CHEMOKINE SIGNALING PATHWAY
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL DN
XU HGF SIGNALING NOT VIA AKT1 6HR
KOBAYASHI EGFR SIGNALING 6HR DN
JISON SICKLE CELL DISEASE UP
CORUM 55S RIBOSOME MITOCHONDRIALMRPL9, MRPS18A, MRPS34, MRPL54, MRPS33, MRPL3, MRPL49, MRPL12, MRPS30, MRPS22, MRPS23, MRPL44, MRPS26, MRPS18B, MRPL11, MRPL27, MRPL34, MRPS7, MRPL41, MRPS12, MRPS16, MRPL35, MRPS11, MRPL32, MRPL40, MRPL36, MRPL18, MRPL1, MRPS2, MRPS17, MRPL50, MRPS24, MRPL43, MRPL53, MRPS31, MRPL21, MRPS35
BREDEMEYER RAG SIGNALING VIA ATM NOT VIA NFKB DN
XU HGF SIGNALING NOT VIA AKT1 48HR UP
CORUM CDC2-PCNA-CCNB1-GADD45G COMPLEX
DASU IL6 SIGNALING UP
HUPER BREAST BASAL VS LUMINAL UP
FUNG IL2 TARGETS WITH STAT5 BINDING SITES T1
ZUCCHI METASTASIS DN
BRUECKNER TARGETS OF MIRLET7A3 UP
HOFFMANN PRE BI TO LARGE PRE BII LYMPHOCYTE DN
SMID BREAST CANCER BASAL UP
ACEVEDO LIVER CANCER WITH H3K27ME3 UP
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
yersinia enterocolitica wap bcyersinia enterocolitica p60 bcGeneSet Name
0.01876 0.08744NETPATH_TGFBETA_RECEPTOR_PATHWAY_UP
0.03066 0.05580NETPATH_TGFBETA_RECEPTOR_PATHWAY_DOWN
0.00010 0.00018NETPATH_IL_2_PATHWAY_UP
0.00001 0.00001NETPATH_IL_1_PATHWAY_UP
0.00017 0.00000NETPATH_IL_4_PATHWAY_UP
0.01695 0.03179NCI_REG_GR_PATHWAY
0.00001 0.00000NCI_IL23PATHWAY
0.00001 0.00159NETPATH_IL_5_PATHWAY_UP
0.00013 0.00510GERY_CEBP_TARGETS
0.00156 0.00140NCI_IL12_2PATHWAY
0.00024 0.00040NETPATH_IL_4_PATHWAY_DOWN
0.00004 0.00570NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.00000 0.00000NETPATH_TNF_ALPHA_PATHWAY_DOWN
0.00720 0.00318NCI_IL27PATHWAY
0.00014 0.00205NETPATH_EGFR1_PATHWAY_UP
0.00052 0.00028NETPATH_IL_7_PATHWAY_UP
0.00040 0.00891NCI_ATF2_PATHWAY
0.00000 0.00000NETPATH_IL_3_PATHWAY_UP
0.01376 0.08440NCI_AR_TF_PATHWAY
0.00093 0.00206NETPATH_IL_1_PATHWAY
0.00841 0.01166NCI_IL1PATHWAY
0.00000 0.00000NETPATH_IL_6_PATHWAY_UP
0.01624 0.03431NCI_IL12_STAT4PATHWAY
0.00860 0.00023SA_MMP_CYTOKINE_CONNECTION
0.02322 0.00704NCI_IL4_2PATHWAY
0.00001 0.00009NETPATH_IL_9_PATHWAY_UP
0.00132 0.04547NCI_NFKAPPABCANONICALPATHWAY
0.00403 0.01798NCI_ERBB_NETWORK_PATHWAY
0.00562 0.01064NCI_HIF2PATHWAY
0.00059 0.00003BIOCARTA_IL10_PATHWAY
0.07058 0.11468NCI_S1P_S1P1_PATHWAY
0.00000 0.00009MAHAJAN_RESPONSE_TO_IL1A_UP
0.00001 0.00000WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.03413 0.18277MASSARWEH_TAMOXIFEN_RESISTANCE_UP
0.01159 0.01617LI_CISPLATIN_RESISTANCE_UP
0.00004 0.00237LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00011 0.00008BIOCARTA_IL1R_PATHWAY
0.05975 0.13390HUANG_FOXA2_TARGETS_DN
0.00379 0.00008RADAEVA_RESPONSE_TO_IFNA1_UP
0.04270 0.11863SESTO_RESPONSE_TO_UV_C0
0.02677 0.00683BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.00162 0.01370MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP
0.13917 0.02535WANG_SMARCE1_TARGETS_UP
0.07031 0.03022JEON_SMAD6_TARGETS_UP
0.06009 0.02635NCI_DISSOLUTION_OF_FIBRIN_CLOT
0.17698 0.10208MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP
0.06378 0.14873BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.03174 0.14750AGARWAL_AKT_PATHWAY_TARGETS
0.01624 0.00630DORN_ADENOVIRUS_INFECTION_48HR_DN
0.00372 0.11062KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.03883 0.19137NCI_HIF1_TFPATHWAY
0.06817 0.00854TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP
0.00206 0.00014AMIT_EGF_RESPONSE_240_MCF10A
0.00000 0.00000AMIT_SERUM_RESPONSE_60_MCF10A
0.00313 0.01191GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.00178 0.00263HAN_SATB1_TARGETS_DN
0.10867 0.06346MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
0.00152 0.01313TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
0.00000 0.00000REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.00000 0.00000SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.00288 0.01756SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP
0.04070 0.11073FRASOR_TAMOXIFEN_RESPONSE_UP
0.00000 0.00020GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.17620 0.18882KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN
0.00000 0.00004AMIT_EGF_RESPONSE_120_HELA
0.02648 0.07269VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
0.00178 0.06188FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
0.00000 0.00008MCLACHLAN_DENTAL_CARIES_UP
0.00903 0.00443GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.00040 0.00028HELLER_SILENCED_BY_METHYLATION_UP
0.17915 0.17520NCI_ACTIVATION_OF_NOXA_AND_TRANSLOCATION_TO_MITOCHONDRIA
0.01073 0.00135GOZGIT_ESR1_TARGETS_DN
0.07010 0.07775NCI_P38ALPHABETAPATHWAY
0.18780 0.06797BIOCARTA_MONOCYTE_PATHWAY
0.00824 0.00148SMID_BREAST_CANCER_LUMINAL_B_DN
0.10957 0.00316BERNARD_PPAPDC1B_TARGETS_DN
0.00120 0.02319SASSON_RESPONSE_TO_GONADOTROPHINS_DN
0.17454 0.06284CORUM_REL-MAP3K8-RELA-TNIP2-PAPOLA_COMPLEX
0.00323 0.00217DORN_ADENOVIRUS_INFECTION_24HR_DN
0.12153 0.11616PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.04253 0.09517MARSON_FOXP3_TARGETS_STIMULATED_UP
0.03002 0.07448FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.00000 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.00643 0.03705AMIT_EGF_RESPONSE_40_MCF10A
0.10388 0.01232REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.14413 0.19773SPIRA_SMOKERS_LUNG_CANCER_UP
0.11680 0.13627CORUM_IKBEPSILON-RELA-CREL_COMPLEX
0.02172 0.13679ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.06082 0.17046CAIRO_LIVER_DEVELOPMENT_UP
0.00188 0.00892CHASSOT_SKIN_WOUND
0.00000 0.00000TIAN_TNF_SIGNALING_VIA_NFKB
0.18767 0.05260ST_STAT3_PATHWAY
0.00177 0.00219KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.09395 0.06783MURAKAMI_UV_RESPONSE_1HR_DN
0.10174 0.06790CORUM_NFKB1-NFKB2-REL-RELA-RELB_COMPLEX
0.00081 0.00004CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.00007 0.00028CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.00107 0.00145MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.02331 0.10732CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5
0.05709 0.04783BROWNE_HCMV_INFECTION_12HR_UP
0.02108 0.11765SESTO_RESPONSE_TO_UV_C1
0.08980 0.11169BROWNE_HCMV_INFECTION_24HR_DN
0.05910 0.15793MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5
0.00821 0.04892SIMBULAN_UV_RESPONSE_NORMAL_UP
0.00014 0.00041KIM_LRRC3B_TARGETS
0.08685 0.11710CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP
0.00040 0.04786RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.00124 0.01065CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.07197 0.13324LIN_NPAS4_TARGETS_DN
0.10752 0.10706NCI_LYSOPHOSPHOLIPID_PATHWAY
0.00176 0.00471KEGG_PRION_DISEASES
0.07894 0.09712GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN
0.02600 0.06576FUNG_IL2_SIGNALING_2
0.03696 0.06365SCHAVOLT_TARGETS_OF_TP53_AND_TP63
0.16107 0.17917NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON
0.01076 0.00139GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.00012 0.00299DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.00001 0.00313DIRMEIER_LMP1_RESPONSE_LATE_UP
0.00572 0.01385SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.00004 0.00047BIOCARTA_CYTOKINE_PATHWAY
0.00006 0.00008MARZEC_IL2_SIGNALING_UP
0.07820 0.02061CHIBA_RESPONSE_TO_TSA_DN
0.00120 0.04266ENK_UV_RESPONSE_EPIDERMIS_DN
0.00401 0.04178BIOCARTA_PPARA_PATHWAY
0.00901 0.02450BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.04493 0.09504LE_EGR2_TARGETS_DN
0.01752 0.00013CROMER_TUMORIGENESIS_UP
0.01642 0.13847FRIDMAN_SENESCENCE_UP
0.16478 0.10909CORUM_ITGAV-ITGB3-PPAP2B_COMPLEX
0.08739 0.03241WU_HBX_TARGETS_2_DN
0.00396 0.07460IVANOVA_HEMATOPOIESIS_STEM_CELL
0.00006 0.00000MAHADEVAN_RESPONSE_TO_MP470_UP
0.02287 0.00296CORRE_MULTIPLE_MYELOMA_UP
0.00007 0.00050FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.14903 0.00249NCI_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE
0.19411 0.19083BIOCARTA_TID_PATHWAY
0.12042 0.14439LE_SKI_TARGETS_UP
0.00025 0.00000SANA_RESPONSE_TO_IFNG_UP
0.05131 0.09493BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.00334 0.00739WU_HBX_TARGETS_1_UP
0.00770 0.01388KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN
0.04179 0.09830SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
0.00258 0.02118MURAKAMI_UV_RESPONSE_6HR_UP
0.01079 0.00242DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN
0.00001 0.00000MOSERLE_IFNA_RESPONSE
0.12556 0.04760OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN
0.00001 0.00032WANG_METHYLATED_IN_BREAST_CANCER
0.18815 0.09456BECKER_TAMOXIFEN_RESISTANCE_DN
0.03521 0.19428REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL
0.03834 0.11880ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.00277 0.01007ONDER_CDH1_TARGETS_1_DN
0.00514 0.00695BIOCARTA_GRANULOCYTES_PATHWAY
0.05123 0.07459LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.03180 0.17380SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL
0.01076 0.02727DORSAM_HOXA9_TARGETS_DN
0.00045 0.00017ELVIDGE_HYPOXIA_BY_DMOG_UP
0.04404 0.17165MIZUKAMI_HYPOXIA_UP
0.13833 0.11558TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP
0.00000 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.00153 0.01140KIM_WT1_TARGETS_8HR_UP
0.00000 0.00000PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.06497 0.14639ELVIDGE_HIF1A_TARGETS_DN
0.09993 0.01015LI_CISPLATIN_RESISTANCE_DN
0.00282 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.11747 0.06076HAHTOLA_SEZARY_SYNDROM_DN
0.05073 0.00417REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
0.04397 0.04676PEREZ_TP53_AND_TP63_TARGETS
0.06841 0.01878REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS
0.15966 0.19343CORUM_MT1-MMP-CLAUDIN-1_COMPLEX
0.00000 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.01376 0.14810MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.07867 0.15973GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN
0.00011 0.00041CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.00970 0.10276HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
0.04260 0.01369MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
0.09982 0.05746KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION
0.01174 0.00443KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP
0.14195 0.02377VECCHI_GASTRIC_CANCER_EARLY_DN
0.13666 0.18185TSENG_IRS1_TARGETS_DN
0.07939 0.13844XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP
0.06013 0.07251CORUM_IKBBETA-RELA-CREL_COMPLEX
0.09294 0.17179NCI_SYNDECAN_1_PATHWAY
0.01552 0.14881YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.00470 0.03708BIOCARTA_NKT_PATHWAY
0.00542 0.07132MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.07825 0.11360ZHAN_MULTIPLE_MYELOMA_CD2_UP
0.08946 0.07282NCI_IL6_7PATHWAY
0.00000 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.00057 0.02207TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN
0.11374 0.17322NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON
0.19778 0.13631LIEN_BREAST_CARCINOMA_METAPLASTIC
0.06063 0.14688CORUM_CELL_CYCLE_KINASE_COMPLEX_CDC2
0.03831 0.00741ROETH_TERT_TARGETS_UP
0.02964 0.00729TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.00992 0.00240BIOCARTA_LAIR_PATHWAY
0.04407 0.19949DAZARD_UV_RESPONSE_CLUSTER_G3
0.08630 0.06140OSADA_ASCL1_TARGETS_DN
0.00008 0.00032NUYTTEN_EZH2_TARGETS_UP
0.08498 0.04751BIOCARTA_LYM_PATHWAY
0.00003 0.00013DUTTA_APOPTOSIS_VIA_NFKB
0.13733 0.04795NCI_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS
0.14976 0.05998NCI_NECTIN_PATHWAY
0.00850 0.00263DER_IFN_GAMMA_RESPONSE_UP
0.00333 0.02211DAZARD_UV_RESPONSE_CLUSTER_G4
0.00340 0.00725MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
0.00000 0.00000ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.00121 0.05249RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.00560 0.00200BIOCARTA_ERYTH_PATHWAY
0.00012 0.00659NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.00898 0.00076HOQUE_METHYLATED_IN_CANCER
0.01325 0.03715NEWMAN_ERCC6_TARGETS_UP
0.05725 0.02325CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_CHUK_KPNA3_NFKB2_NFKBIB_REL_IKBKG__NFKB1_NFKBIE_RELB__NFKBIA_RELA_TNIP2
0.14105 0.11098NETPATH_HEDGEHOG_PATHWAY_UP
0.00000 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00000 0.00000GAURNIER_PSMD4_TARGETS
0.01810 0.00039FARMER_BREAST_CANCER_CLUSTER_1
0.00368 0.00097GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.03490 0.11465SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.00565 0.02548MARKEY_RB1_CHRONIC_LOF_DN
0.04257 0.06695CORUM_TOP1-PSF-P54_COMPLEX
0.14177 0.02126BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
0.00000 0.00004GESERICK_TERT_TARGETS_DN
0.00000 0.00000AMIT_SERUM_RESPONSE_120_MCF10A
0.07080 0.01117LEE_LIVER_CANCER_MYC_E2F1_UP
0.03197 0.10478NCI_IL2_1PATHWAY
0.14246 0.08441WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
0.00000 0.00000GEISS_RESPONSE_TO_DSRNA_UP
0.02956 0.00226SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.17372 0.01794CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_RPL6_RPL30_RPS13_CHUK_DDX3X_NFKB2_NFKBIB_REL_IKBKG_NFKB1_MAP3K8_RELB_GLG1_NFKBIA_RELA_TNIP2__GTF2I
0.01077 0.06793GENTILE_UV_HIGH_DOSE_DN
0.00565 0.01229BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN
0.00001 0.00000ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.17594 0.01878REACTOME_GPCR_LIGAND_BINDING
0.00480 0.15514GRUETZMANN_PANCREATIC_CANCER_UP
0.13316 0.18860ST_PAC1_RECEPTOR_PATHWAY
0.01782 0.00041OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.03825 0.06758ABE_VEGFA_TARGETS_2HR
0.02052 0.00675VALK_AML_CLUSTER_2
0.00024 0.01120KRIGE_AMINO_ACID_DEPRIVATION
0.07084 0.08720KOMMAGANI_TP63_GAMMA_TARGETS
0.00000 0.00000AMIT_EGF_RESPONSE_60_MCF10A
0.00001 0.00000KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.01068 0.02172CHEN_HOXA5_TARGETS_6HR_UP
0.00133 0.00508SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00652 0.02593LEONARD_HYPOXIA
0.00451 0.00146BONCI_TARGETS_OF_MIR15A_AND_MIR16_1
0.05654 0.05832CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN
0.01879 0.00471DORN_ADENOVIRUS_INFECTION_32HR_DN
0.09748 0.00041WU_CELL_MIGRATION
0.00000 0.00000WALLACE_PROSTATE_CANCER_RACE_UP
0.04629 0.13971CHANDRAN_METASTASIS_DN
0.15249 0.09635NETPATH_IL_7_PATHWAY_DOWN
0.00898 0.07654BIOCARTA_CCR5_PATHWAY
0.04922 0.09741KEGG_MAPK_SIGNALING_PATHWAY
0.01741 0.01063ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.01934 0.02619GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.03095 0.09717ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
0.02246 0.02143BIOCARTA_IL12_PATHWAY
0.00537 0.00028UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.13301 0.11754BROWNE_HCMV_INFECTION_30MIN_UP
0.00000 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.00000 0.00008FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.00233 0.02444CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.00057 0.02878KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.02746 0.14793WU_HBX_TARGETS_2_UP
0.19416 0.04229WILLERT_WNT_SIGNALING
0.09822 0.17598SWEET_LUNG_CANCER_KRAS_DN
0.03334 0.03816TSAI_DNAJB4_TARGETS_DN
0.07276 0.04900BIOCARTA_DC_PATHWAY
0.04915 0.18663YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6
0.00000 0.00004TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.00773 0.00077LI_PROSTATE_CANCER_EPIGENETIC
0.01073 0.17956GOLDRATH_ANTIGEN_RESPONSE
0.00000 0.00000BILD_HRAS_ONCOGENIC_SIGNATURE
0.06147 0.02597DAUER_STAT3_TARGETS_UP
0.00007 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.08588 0.00264RIGGI_EWING_SARCOMA_PROGENITOR_DN
0.01898 0.00389DER_IFN_ALPHA_RESPONSE_UP
0.00167 0.06772MENSE_HYPOXIA_UP
0.14668 0.13478NCI_TRAFFICKING_OF_AMPA_RECEPTORS
0.10073 0.07438PETRETTO_CARDIAC_HYPERTROPHY
0.05422 0.14150REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION
0.00000 0.00060BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.00000 0.00028AMIT_EGF_RESPONSE_60_HELA
0.00197 0.06783ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.00772 0.01385DAZARD_UV_RESPONSE_CLUSTER_G2
0.00069 0.16353AMUNDSON_DNA_DAMAGE_RESPONSE_TP53
0.01162 0.00724MARKS_HDAC_TARGETS_DN
0.00001 0.00014MCLACHLAN_DENTAL_CARIES_DN
0.00070 0.01133KEGG_ALLOGRAFT_REJECTION
0.09902 0.18351NCI_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS
0.00000 0.00000ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00006 0.00004BIOCARTA_INFLAM_PATHWAY
0.00000 0.00000SANA_TNF_SIGNALING_UP
0.00001 0.00026SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.00000 0.00048AMIT_EGF_RESPONSE_240_HELA
0.08510 0.09232SHI_SPARC_TARGETS_DN
0.00000 0.00006HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.05313 0.12408GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP
0.00048 0.00041CASTELLANO_NRAS_TARGETS_UP
0.02767 0.06186CORUM_TLE-HISTONE_H3_COMPLEX
0.00344 0.00057KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.05211 0.00360SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.08565 0.04175VICENT_METASTASIS_DN
0.02098 0.06720SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
0.04442 0.03278VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.01077 0.17749KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN
0.00000 0.00000UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.03525 0.14087BIOCARTA_KERATINOCYTE_PATHWAY
0.09642 0.14089CORUM_UBIQUITIN_LIGASE_COMPLEX_TRAF6_TAB2_MALT1_UEV1A_BCL10
0.00223 0.03308CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP
0.00558 0.07719CHIBA_RESPONSE_TO_TSA_UP
0.01757 0.13193HELLER_HDAC_TARGETS_DN
0.00000 0.00000GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.03839 0.13492CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN
0.00294 0.01389GOUYER_TATI_TARGETS_UP
0.08680 0.09816ZHAN_MULTIPLE_MYELOMA_HP_UP
0.13684 0.18588NCI_GLUCOSE___ATP____GLUCOSE_6_PHOSPHATE___ADP
0.00006 0.00004LU_IL4_SIGNALING
0.02654 0.00697WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN
0.00000 0.00000GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.04118 0.03900BIOCARTA_STEM_PATHWAY
0.02462 0.02934SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS
0.01359 0.03120BIOCARTA_NFKB_PATHWAY
0.00193 0.00738VANHARANTA_UTERINE_FIBROID_DN
0.00193 0.00358LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.05875 0.11943CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.00024 0.00055KEGG_GRAFT_VERSUS_HOST_DISEASE
0.00120 0.15192VARELA_ZMPSTE24_TARGETS_UP
0.00793 0.01911ONDER_CDH1_TARGETS_2_UP
0.00741 0.00005REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.01105 0.14109NGUYEN_NOTCH1_TARGETS_UP
0.00784 0.00671BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.02335 0.00020KRASNOSELSKAYA_ILF3_TARGETS_UP
0.00001 0.00008RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.05679 0.05562CORUM_CDC2-PCNA-CCNB1-GADD45B_COMPLEX
0.01065 0.00171LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.05414 0.08984ODONNELL_TFRC_TARGETS_UP
0.01664 0.02137GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.06007 0.00492IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.00018 0.00031AMIT_EGF_RESPONSE_40_HELA
0.04401 0.03689KIM_WT1_TARGETS_12HR_DN
0.18147 0.16745GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN
0.06916 0.11727BILD_CTNNB1_ONCOGENIC_SIGNATURE
0.00513 0.10630MITSIADES_RESPONSE_TO_APLIDIN_UP
0.00000 0.00000THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.00012 0.00004TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.00000 0.00000HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.00001 0.00004MARKEY_RB1_ACUTE_LOF_UP
0.00751 0.00049XU_AKT1_TARGETS_6HR
0.05055 0.01364KEGG_TYPE_II_DIABETES_MELLITUS
0.08053 0.08583HUANG_FOXA2_TARGETS_UP
0.02001 0.02172TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.00162 0.00652POOLA_INVASIVE_BREAST_CANCER_UP
0.02588 0.02321SABATES_COLORECTAL_ADENOMA_UP
0.02102 0.05037WOTTON_RUNX_TARGETS_UP
0.00439 0.03733RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.11363 0.08100LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.07003 0.01254BROWNE_HCMV_INFECTION_6HR_UP
0.00458 0.00220DAUER_STAT3_TARGETS_DN
0.02104 0.01255BIOCARTA_RANKL_PATHWAY
0.00106 0.04558DANG_REGULATED_BY_MYC_DN
0.07823 0.06147NCI_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.04285 0.18228STOSSI_RESPONSE_TO_ESTRADIOL
0.05323 0.18782BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP
0.18184 0.19246CORUM_PLEXINA1-NRP2_COMPLEX
0.05269 0.09517WHITESIDE_CISPLATIN_RESISTANCE_UP
0.00007 0.00857SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.00000 0.00001PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.00069 0.00384JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
0.11935 0.13477KAPOSI_LIVER_CANCER_POOR_SURVIVAL_UP
0.00205 0.00219LEE_LIVER_CANCER_E2F1_UP
0.03856 0.08606PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION
0.00632 0.00077BOWIE_RESPONSE_TO_TAMOXIFEN
0.08687 0.17387GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN
0.12166 0.07977HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER
0.00000 0.00000ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.00008 0.00218ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.01811 0.12816SUNG_METASTASIS_STROMA_UP
0.06676 0.16479VANTVEER_BREAST_CANCER_ESR1_DN
0.07820 0.11080STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN
0.00001 0.00068BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.12183 0.06307LY_AGING_MIDDLE_DN
0.10906 0.04809RUGO_STRESS_RESPONSE_SUBSET_F
0.00897 0.06856BARRIER_COLON_CANCER_RECURRENCE_DN
0.01652 0.13034NCI_P53DOWNSTREAMPATHWAY
0.04533 0.16340BIOCARTA_ATM_PATHWAY
0.09804 0.09638BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
0.00750 0.01341GENTILE_UV_LOW_DOSE_UP
0.00488 0.07647BIOCARTA_P53HYPOXIA_PATHWAY
0.00025 0.00000HUANG_DASATINIB_RESISTANCE_UP
0.01876 0.01504PEREZ_TP63_TARGETS
0.00001 0.00008HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.00114 0.00013ZHANG_INTERFERON_RESPONSE
0.13315 0.02414JI_METASTASIS_REPRESSED_BY_STK11
0.07816 0.00008CHANG_IMMORTALIZED_BY_HPV31_DN
0.00829 0.01017CROONQUIST_STROMAL_STIMULATION_UP
0.00059 0.00008CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.07698 0.04879KANG_GIST_WITH_PDGFRA_UP
0.12153 0.17898CORUM_BRCA1_B_COMPLEX
0.01070 0.17156KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN
0.01741 0.06983LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP
0.02929 0.01394KHETCHOUMIAN_TRIM24_TARGETS_UP
0.00023 0.00038HORIUCHI_WTAP_TARGETS_UP
0.00001 0.00000WOO_LIVER_CANCER_RECURRENCE_UP
0.01175 0.00041DORN_ADENOVIRUS_INFECTION_12HR_UP
0.00132 0.01530DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
0.00825 0.11506HENDRICKS_SMARCA4_TARGETS_UP
0.19320 0.03244RIGGI_EWING_SARCOMA_PROGENITOR_UP
0.01863 0.03924CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN
0.00899 0.02068BUDHU_LIVER_CANCER_METASTASIS_DN
0.00277 0.00015KEGG_JAK_STAT_SIGNALING_PATHWAY
0.17539 0.02618TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.16954 0.02491TSAI_DNAJB4_TARGETS_UP
0.00563 0.00056DER_IFN_BETA_RESPONSE_UP
0.02613 0.03210SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4
0.00004 0.00020TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.06878 0.06168SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER
0.00000 0.00003BASSO_CD40_SIGNALING_UP
0.09968 0.01619MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.09524 0.06178NCI_ERBB4_PATHWAY
0.08688 0.11543WILLIAMS_ESR1_TARGETS_UP
0.00034 0.00078TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.15543 0.06566CHANG_POU5F1_TARGETS_UP
0.00000 0.00000NAGASHIMA_NRG1_SIGNALING_UP
0.16203 0.12784ZERBINI_RESPONSE_TO_SULINDAC_UP
0.01616 0.06088WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.01753 0.02899FRASOR_RESPONSE_TO_ESTRADIOL_DN
0.09549 0.03245REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS
0.04542 0.04992TSENG_ADIPOGENIC_POTENTIAL_DN
0.00361 0.09144NETPATH_B_CELL_RECEPTOR_PATHWAY_UP
0.02441 0.03850SCHURINGA_STAT5A_TARGETS_UP
0.00301 0.03231SASSON_RESPONSE_TO_FORSKOLIN_DN
0.11477 0.09807SMID_BREAST_CANCER_NORMAL_LIKE_UP
0.00784 0.07047BIOCARTA_P53_PATHWAY
0.07506 0.12327CADWELL_ATG16L1_TARGETS_UP
0.03958 0.04758KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.10735 0.11078MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS
0.00001 0.00005ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.00753 0.13001CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4
0.18469 0.19065SIG_CD40PATHWAYMAP
0.00695 0.01693KEGG_LEISHMANIA_INFECTION
0.08786 0.04771YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN
0.05224 0.19435ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN
0.00040 0.00515MASSARWEH_RESPONSE_TO_ESTRADIOL
0.11114 0.11308FUNG_IL2_SIGNALING_1
0.00001 0.00074CHEN_HOXA5_TARGETS_9HR_UP
0.00893 0.02120WANG_RECURRENT_LIVER_CANCER_DN
0.01326 0.09688RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00008 0.00030GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00014 0.00226CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.03824 0.13315ENGELMANN_CANCER_PROGENITORS_UP
0.00344 0.09721LEE_RECENT_THYMIC_EMIGRANT
0.00019 0.01041BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
0.00000 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.02830 0.13527BIOCARTA_ASBCELL_PATHWAY
0.00001 0.00109SENESE_HDAC1_TARGETS_UP
0.03136 0.08106LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.00000 0.00000KIM_WT1_TARGETS_UP
0.01094 0.00805KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.00844 0.04785WANG_HCP_PROSTATE_CANCER
0.07820 0.00995BROWNE_HCMV_INFECTION_1HR_UP
0.00000 0.00004HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.00001 0.00028AMIT_EGF_RESPONSE_120_MCF10A
0.01070 0.03196IIZUKA_RECURRENT_LIVER_CANCER
0.01134 0.15536NETPATH_WNT_PATHWAY_UP
0.13932 0.11523SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
0.00218 0.01317BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
0.00232 0.05386RUTELLA_RESPONSE_TO_HGF_UP
0.03007 0.17959HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.00024 0.00119PRAMOONJAGO_SOX4_TARGETS_UP
0.06340 0.08587REACTOME_CRMPS_IN_SEMA3A_SIGNALING
0.09440 0.19674LU_TUMOR_ENDOTHELIAL_MARKERS_UP
0.03003 0.00475REACTOME_INORGANIC_CATION_ANION_SLC_TRANSPORTERS
0.05475 0.02683BIOCARTA_PML_PATHWAY
0.01066 0.05114LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.00452 0.00361MARCHINI_TRABECTEDIN_RESISTANCE_DN
0.07725 0.02423TENEDINI_MEGAKARYOCYTE_MARKERS
0.14424 0.04185SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
0.00000 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.09812 0.00249REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS
0.04458 0.07466XU_RESPONSE_TO_TRETINOIN_UP
0.09449 0.07658BASAKI_YBX1_TARGETS_DN
0.06631 0.11084HOFMANN_CELL_LYMPHOMA_DN
0.00006 0.00036ELVIDGE_HYPOXIA_UP
0.01513 0.01514WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN
0.00071 0.07509STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA
0.04667 0.14786FARMER_BREAST_CANCER_BASAL_VS_LULMINAL
0.17828 0.04020RIZ_ERYTHROID_DIFFERENTIATION_12HR
0.03424 0.11392NUYTTEN_NIPP1_TARGETS_UP
0.17894 0.04782ST_TYPE_I_INTERFERON_PATHWAY
0.00086 0.00669GENTILE_UV_RESPONSE_CLUSTER_D1
0.00000 0.00008KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.19848 0.03724NCI_GAMMA_CARBOXYLATION_OF_PROTEIN_PRECURSORS
0.08855 0.08114MURATA_VIRULENCE_OF_H_PILORI
0.00218 0.00016VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.02050 0.01761DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN
0.04920 0.06295BIOCARTA_IL22BP_PATHWAY
0.01296 0.01025ROZANOV_MMP14_TARGETS_DN
0.05125 0.19909TSAI_RESPONSE_TO_IONIZING_RADIATION
0.01537 0.08331DELYS_THYROID_CANCER_UP
0.00000 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.02292 0.02551AMIT_SERUM_RESPONSE_240_MCF10A
0.04194 0.02874SEMENZA_HIF1_TARGETS
0.16519 0.00103MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN
0.00073 0.00003BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.00895 0.16753BIOCARTA_ETS_PATHWAY
0.00259 0.09530NCI_NFAT_TFPATHWAY
0.01083 0.00099ONDER_CDH1_TARGETS_3_DN
0.15947 0.16577CORUM_PCNA-P21_COMPLEX
0.10223 0.08621NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.00401 0.00048HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.00074 0.02049LIAN_LIPA_TARGETS_6M
0.00323 0.01065DAZARD_RESPONSE_TO_UV_NHEK_UP
0.00004 0.00442WINTER_HYPOXIA_METAGENE
0.04343 0.10741BROWNE_HCMV_INFECTION_8HR_UP
0.00000 0.00001GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.01106 0.02930TAVOR_CEBPA_TARGETS_UP
0.02085 0.04741RAY_ALZHEIMERS_DISEASE
0.05837 0.13046OSAWA_TNF_TARGETS
0.10111 0.07439SASAKI_TARGETS_OF_TP73_AND_TP63
0.00410 0.01384PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.01532 0.14780NETPATH_TNF_ALPHA_PATHWAY_UP
0.04505 0.00186NCI_AMB2_NEUTROPHILS_PATHWAY
0.00893 0.00097NOJIMA_SFRP2_TARGETS_DN
0.04992 0.12402NGUYEN_NOTCH1_TARGETS_DN
0.02213 0.00673BROWNE_HCMV_INFECTION_2HR_UP
0.03803 0.10056WANG_RESPONSE_TO_PACLITAXEL_VIA_MAPK8_UP
0.03004 0.11734KIM_WT1_TARGETS_12HR_UP
0.01696 0.03461ZIRN_TRETINOIN_RESPONSE_UP
0.00406 0.00270SESTO_RESPONSE_TO_UV_C3
0.11379 0.03839HASLINGER_B_CLL_WITH_MUTATED_VH_GENES
0.00011 0.00007GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.00006 0.02576SENESE_HDAC2_TARGETS_UP
0.00217 0.00149GRANDVAUX_IRF3_TARGETS_UP
0.17956 0.03349KIM_MYCN_AMPLIFICATION_TARGETS_DN
0.03703 0.12290ROZANOV_MMP14_TARGETS_UP
0.00018 0.00004ZHU_CMV_ALL_UP
0.00193 0.00168LEE_LIVER_CANCER_HEPATOBLAST
0.00000 0.00000NAGASHIMA_EGF_SIGNALING_UP
0.01030 0.02107KEGG_TYPE_I_DIABETES_MELLITUS
0.00156 0.04380AMIT_DELAYED_EARLY_GENES
0.00224 0.00304NOJIMA_SFRP2_TARGETS_UP
0.00000 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.00753 0.10486NETPATH_EGFR1_PATHWAY_DOWN
0.02849 0.02539RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
0.08470 0.00887SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER
0.01684 0.14773RUIZ_TNC_TARGETS_UP
0.00696 0.00112RODRIGUES_THYROID_CARCINOMA_DN
0.01777 0.00824AUJLA_IL22_AND_IL17A_SIGNALING
0.18770 0.14131LEE_LIVER_CANCER_MYC_TGFA_UP
0.02062 0.13016DAZARD_RESPONSE_TO_UV_SCC_UP
0.00154 0.00037HALMOS_CEBPA_TARGETS_UP
0.00001 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.02459 0.07586SAGIV_CD24_TARGETS_DN
0.01327 0.15491AUNG_GASTRIC_CANCER
0.05867 0.03245NETPATH_IL_7_PATHWAY
0.01324 0.00057DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN
0.01379 0.08414WIELAND_UP_BY_HBV_INFECTION
0.03886 0.00032REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE
0.00006 0.00009MAHADEVAN_RESPONSE_TO_MP470_DN
0.05427 0.04319RIGGINS_TAMOXIFEN_RESISTANCE_DN
0.15103 0.00488LEE_INTRATHYMIC_T_PROGENITOR
0.01725 0.02101TSAI_RESPONSE_TO_RADIATION_THERAPY
0.05321 0.17973NCI_CXCR3PATHWAY
0.00004 0.00029HARRIS_HYPOXIA
0.03417 0.07578CORUM_SNRNP-FREE_U1A_SF-A_COMPLEX
0.08477 0.16308NCI_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS
0.03922 0.16337RUIZ_TNC_TARGETS_DN
0.00286 0.00121KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.00001 0.00008SOUCEK_MYC_TARGETS
0.08091 0.01283BIOCARTA_IL5_PATHWAY
0.00417 0.07987SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.00001 0.00101BILBAN_B_CLL_LPL_DN
0.12181 0.06249IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.00814 0.01983GENTILE_UV_LOW_DOSE_DN
0.00337 0.00021ZHAN_MULTIPLE_MYELOMA_LB_DN
0.17971 0.11422KEGG_AUTOIMMUNE_THYROID_DISEASE
0.00219 0.00353SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.00478 0.13864CHIN_BREAST_CANCER_COPY_NUMBER_UP
0.16232 0.03995WILCOX_PRESPONSE_TO_ROGESTERONE_DN
0.00342 0.02115WANG_ESOPHAGUS_CANCER_PROGRESSION_UP
0.01324 0.00009EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.07837 0.12851LEE_SP4_THYMOCYTE
0.08467 0.12298CHANG_POU5F1_TARGETS_DN
0.00000 0.00004AMIT_SERUM_RESPONSE_40_MCF10A
0.05016 0.14656GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
0.01551 0.01760HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
0.00120 0.01341MASSARWEH_TAMOXIFEN_RESISTANCE_DN
0.00028 0.00000BROWNE_HCMV_INFECTION_4HR_UP
0.04580 0.02311WONG_ENDOMETRIAL_CANCER_LATE
0.02086 0.00586BIOCARTA_HSP27_PATHWAY
0.00004 0.00000ZHU_CMV_8_HR_UP
0.00072 0.01398HELLER_SILENCED_BY_METHYLATION_DN
0.00509 0.02071BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.00001 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.00001 0.00023SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.00321 0.02068XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR
0.00111 0.00011ONDER_CDH1_TARGETS_2_DN
0.07020 0.11068GRADE_COLON_VS_RECTAL_CANCER_UP
0.00944 0.09043UDAYAKUMAR_MED1_TARGETS_DN
0.00001 0.00039SENESE_HDAC3_TARGETS_UP
0.00070 0.01896LIAN_LIPA_TARGETS_3M
0.00276 0.00858KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.00145 0.00917CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
0.00157 0.02133XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.14658 0.11776KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.00072 0.00209JISON_SICKLE_CELL_DISEASE_UP
0.00000 0.00000CORUM_55S_RIBOSOME_MITOCHONDRIAL
0.02965 0.14765BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN
0.00258 0.00517XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.05963 0.09827CORUM_CDC2-PCNA-CCNB1-GADD45G_COMPLEX
0.00001 0.00020DASU_IL6_SIGNALING_UP
0.02163 0.00030HUPER_BREAST_BASAL_VS_LUMINAL_UP
0.11670 0.19115FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1
0.00010 0.05022ZUCCHI_METASTASIS_DN
0.00513 0.00209BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.16897 0.16317HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN
0.00269 0.00039SMID_BREAST_CANCER_BASAL_UP
0.05905 0.03339ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP